<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1 20151215//EN" "JATS-archivearticle1.dtd"> 
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="letter"><?properties open_access?><?DTDIdentifier.IdentifierValue -//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.0 20120330//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName JATS-journalpublishing1.dtd?><?SourceDTD.Version 1.0?><?ConverterInfo.XSLTName jp2nlmx2.xsl?><?ConverterInfo.Version 2?><front><journal-meta><journal-id journal-id-type="nlm-ta">An Bras Dermatol</journal-id><journal-id journal-id-type="iso-abbrev">An Bras Dermatol</journal-id><journal-id journal-id-type="publisher-id">abd</journal-id><journal-title-group><journal-title>Anais Brasileiros de Dermatologia</journal-title></journal-title-group><issn pub-type="ppub">0365-0596</issn><issn pub-type="epub">1806-4841</issn><publisher><publisher-name>Sociedade Brasileira de Dermatologia</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">5087248</article-id><article-id pub-id-type="doi">10.1590/abd1806-4841.20165345</article-id><article-categories><subj-group subj-group-type="heading"><subject>Letters</subject></subj-group></article-categories><title-group><article-title>When strength turns into disease: acne fulminans in a
bodybuilder<xref ref-type="fn" rid="fn1">*</xref></article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Perez</surname><given-names>Mario</given-names></name><xref ref-type="aff" rid="aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>Navajas-Galimany</surname><given-names>Lucas</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="corresp" rid="c1"/></contrib><contrib contrib-type="author"><name><surname>Antunez-Lay</surname><given-names>Andrea</given-names></name><xref ref-type="aff" rid="aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>Hasson</surname><given-names>Ariel</given-names></name><xref ref-type="aff" rid="aff1">1</xref></contrib><aff id="aff1"><label>1</label>Pontificia Universidad Cat&#x000f3;lica de Chile &#x02013;
Santiago, Chile</aff></contrib-group><author-notes><corresp id="c1">Mailing address: Lucas Navajas-Galimany, Av. Vicu&#x000f1;a Mackenna
4686, Santiago, Chile. E-mail: <email>lfnavaja@uc.cl</email></corresp></author-notes><pub-date pub-type="epub-ppub"><season>Sep-Oct</season><year>2016</year></pub-date><!--Fake ppub date generated by PMC from publisher
							pub-date/@pub-type='epub-ppub' --><pub-date pub-type="ppub"><season>Sep-Oct</season><year>2016</year></pub-date><volume>91</volume><issue>5</issue><fpage>706</fpage><lpage>706</lpage><history><date date-type="received"><day>07</day><month>11</month><year>2015</year></date><date date-type="accepted"><day>16</day><month>12</month><year>2015</year></date></history><permissions><copyright-statement>&#x000a9;2016 by Anais Brasileiros de
Dermatologia</copyright-statement><copyright-year>2016</copyright-year><copyright-holder>Anais Brasileiros de Dermatologia</copyright-holder><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by-nc/4.0/"><license-p>This is an Open Access article distributed under the terms of the
Creative Commons Attribution Non-Commercial License which permits
unrestricted non-commercial use, distribution, and reproduction in any
medium provided the original work is properly cited.</license-p></license></permissions></article-meta></front><body><p>To the Editor:</p><p>A 31-year-old male visited our hospital seeking dermatological care. He had been
bodybuilding for a long time and had recently initiated a strict preparation program for
a contest. To this end, he took intramuscular testosterone injections on three
occasions, developing severe acneiform lesions. The course was gradual but progressive,
leading to limitations in his daily activities, with arthralgia of the shoulders and
ankles, as well as difficulty to work, move, change clothes and even sleep at night. No
fever was reported. Initial testing revealed: a white blood count of 12.570/
mm<sup>3</sup>; an erythrocyte sedimentation rate of 50mm/h; a platelet count of
278.000/mm<sup>3</sup>, without liver abnormalities. Upon physical examination,
multiple, nodulocystic, erythematous papules and pustules were found on his face, chest,
back and arms. Extensive ulcerations with brown-yellowish thick crusts were scattered
mainly over his shoulders, the proximal areas of both arms and the upper back (<xref ref-type="fig" rid="f1">Figure 1</xref>). The diagnosis of acne fulminans was made
and treatment was initiated with prednisone 45mg/daily, doxycycline 100mg twice daily
and antihistamines. He was told to definitively discontinue hormonal treatment. Four
weeks later, isotretinoin was started at an initial dose of 30mg/daily and
corticosteroids were gradually tapered. A good clinical response was achieved, with
progressive healing. Acne fulminans is a rare condition, considered the most severe form
of acne.<sup><xref rid="r1" ref-type="bibr">1</xref></sup> It usually affects young
individuals aged 13-22 years, predominantly males with a prior history of mild or
moderate acne<sup><xref rid="r2" ref-type="bibr">2</xref></sup>. It is characterized by
the sudden onset of highly inflammatory, ulcerative, painful lesions covered with
haemorrhagic crusts, most often located on the upper chest and back.<sup><xref rid="r2" ref-type="bibr">2</xref></sup> Constitutional symptoms and laboratory
abnormalities are frequently seen, as in this case. The etiology of acne fulminans
remains unclear but it appears to be multifactorial. Doping acne is a variant, induced
by exogenous hormones (EHs) such as testosterone or derivatives, provoking hypertrophy
of the sebaceous glands, increased production of skin surface lipids and sebum, in
addition to increased density of the <italic>Propionibacterium acnes</italic>
population.<sup><xref rid="r3" ref-type="bibr">3</xref>,<xref rid="r4" ref-type="bibr">4</xref></sup> The prevalence of EH usage is increasing dramatically,
especially among amateur bodybuilders (reaching up to 80%) and weightlifters (38-58%).
This is favored by the non-therapeutic prescription of EH by some physicians who are
unaware of its side effects. It has been estimated that up to 50% of users could develop
doping acne.<sup><xref rid="r3" ref-type="bibr">3</xref></sup> Certainly, the most
important indication in these cases is the immediate cessation of EH. Due to severe,
systemic symptoms, supportive care, along with a 4-6 week course of systemic
corticosteroids, must be considered as first-line therapy. Subsequent addition of
systemic retinoids is recommended, starting with 0.5 mg/kg daily, with a gradual dose
increase to achieve early control of constitutional features as well as clearance of
lesions.<sup><xref rid="r5" ref-type="bibr">5</xref></sup> It is imperative
nowadays to pay special attention to society's growing interest in having a perfectly
sculpted body. Acne is a condition commonly associated with the use of hormonal
therapies and its severe forms represent one of the risks that must be diagnosed and
treated promptly.</p><p><fig id="f1" orientation="portrait" position="float"><label>Figure 1</label><caption><p>Multiple erythematous nodules, papules, pustules and ulcerations with
brown-yellowish thick crusts on the chest, shoulders and arms</p></caption><graphic xlink:href="abd-91-05-0706-g01"/></fig></p></body><back><fn-group><fn fn-type="COI-statement"><p>Conflict of Interest: None</p></fn><fn fn-type="supported-by"><p>Financial Support: None</p></fn><fn fn-type="other" id="fn1"><label>*</label><p>Work performed at the Department of Dermatology. Facultad de Medicina. Pontificia
Universidad Cat&#x000f3;lica de Chile &#x02013; Santiago, Chile.</p></fn></fn-group><ref-list><title>REFERENCES</title><ref id="r1"><label>1</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Giavedoni</surname><given-names>P</given-names></name><name><surname>Mascar&#x000f3;-Galy</surname><given-names>JM</given-names></name><name><surname>Aguilera</surname><given-names>P</given-names></name><name><surname>Estrach-Panella</surname><given-names>T</given-names></name></person-group><article-title>Acne fulminans successfully treated with cyclosporine and
isotretinoin</article-title><source>J Am Acad Dermatol</source><year>2014</year><volume>70</volume><fpage>e38</fpage><lpage>e39</lpage><pub-id pub-id-type="pmid">24438977</pub-id></element-citation></ref><ref id="r2"><label>2</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zaba</surname><given-names>R</given-names></name><name><surname>Schwartz</surname><given-names>R</given-names></name><name><surname>Jarmuda</surname><given-names>S</given-names></name><name><surname>Czarnecka-Operacz</surname><given-names>M</given-names></name><name><surname>Silny</surname><given-names>W</given-names></name></person-group><article-title>Acne fulminans: explosive systemic form of acne</article-title><source>J Eur Acad Dermatol Venereol</source><year>2011</year><volume>25</volume><fpage>501</fpage><lpage>507</lpage><pub-id pub-id-type="pmid">21029206</pub-id></element-citation></ref><ref id="r3"><label>3</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Walker</surname><given-names>J</given-names></name><name><surname>Adams</surname><given-names>B</given-names></name></person-group><article-title>Cutaneous manifestations of anabolic-androgenic steroid use in
athletes</article-title><source>Int J Dermatol</source><year>2009</year><volume>48</volume><fpage>1044</fpage><lpage>1048</lpage><pub-id pub-id-type="pmid">19785085</pub-id></element-citation></ref><ref id="r4"><label>4</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kraus</surname><given-names>SL</given-names></name><name><surname>Emmert</surname><given-names>S</given-names></name><name><surname>Sch&#x000f6;n</surname><given-names>MP</given-names></name><name><surname>Haenssle</surname><given-names>HA</given-names></name></person-group><article-title>The dark side of beauty acne fulminans induced by anabolic
steroids in a male bodybuilder</article-title><source>Arch Dermatol</source><year>2012</year><volume>148</volume><fpage>1210</fpage><lpage>1212</lpage><pub-id pub-id-type="pmid">23069972</pub-id></element-citation></ref><ref id="r5"><label>5</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lages</surname><given-names>RB</given-names></name><name><surname>Bona</surname><given-names>SH</given-names></name><name><surname>Silva</surname><given-names>FV</given-names></name><name><surname>Gomes</surname><given-names>AK</given-names></name><name><surname>Campelo</surname><given-names>V</given-names></name></person-group><article-title>Acne fulminans successfully treated with prednisone and
dapsone</article-title><source>An Bras Dermatol</source><year>2012</year><volume>87</volume><fpage>612</fpage><lpage>614</lpage><pub-id pub-id-type="pmid">22892777</pub-id></element-citation></ref></ref-list></back></article>